In case you've faced some hurdles solving the clue, Tutorial part, we've got the answer for you. Crossword puzzles offer a fantastic opportunity to engage your mind, enjoy leisure time, and test your ...

'Krishnavataram Part 1: The Heart', directed by Hardik Gajjar, has been pulling drawing in audiences into theatres in large numbers. The epic saga, starring Siddharth Gupta as Lord Krishna, is the ...

According to Sacnilk, the film has collected Rs 8.76 crore in India net collections so far. Its total India gross has reached Rs 10.46 crore. As of Day 6, the film was running in 242 shows and had ...

The film explores how Lord Krishna (Siddharth Gupta) loved with a pure heart and was loved ditto by Radha, Rukmini (who had never even seen him), and Bhama (who was madly in love with him). Krishna ...

An epic devotional narrative that reimagines the journey of Lord Krishna, tracing his path from Dwarka to Kurukshetra after parting ways with Radha. As his journey unfolds, it explores his connection ...

S15 - E19 Reunion Part 1 The reunion kicks off with some of the ladies seeking resolution while others remain doubtful following an emotionally charged season. A red-carpet sighting sparks questions ...

Year 7 (Part 1) is the last and final year in LEGO Harry Potter: Years 5-7. The year is split up into two parts, and explores the events that took place in the first half of J.K Rowling’s Harry Potter ...

Structure Therapeutics reported highly positive Phase 2 ACCESS II data for aleniglipron, achieving ~16% placebo-adjusted weight loss with strong statistical significance and no plateau. Aleniglipron’s ...

A Structure Therapeutics obesity pill helped patients lose an average of nearly 40 pounds in a mid-stage clinical trial, keeping the drug competitive in the growing crowd of oral medications pursuing ...

The plan for Structure Therapeutics is to meet with the FDA on its oral GLP-1 drug in the second quarter ahead of an anticipated phase 3 launch in the second half of ...

This year could be a key one for Structure, as the company's GLP-1 weight loss pill, aleniglipron, enters phase 3 trials. If the results prove to be strong, then it may only be a matter of time before ...

Roche obtained a nonexclusive license to certain patents from Structure Therapeutics related to the Swiss pharma's oral GLP-1 candidate CT-996. (tolgart/iStock/Getty Images Plus) In a strategic move ...